Baclofen Deal Offers Amneal Biosimilars Advantage

Firm Accelerates Biosimilars Schedule, With Three Launches Now Planned For This Year

 
• By David Wallace
  
Three rockets launch clouds space
Three biosimilar launches are planned this year for Amneal • Source: Emilija Randjelovic / Alamy Stock Vector
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business